Polymorphisms of MTHFR Associated with Higher Relapse/Death Ratio and Delayed Weekly MTX Administration in Pediatric Lymphoid Malignancies

Table 1

Patient characteristics.

Diagnosis	ALL	BCP	69
		T	9
		Other	4
	NHL	Burkitt	10
		DLBCL	2
		T	5
		Other	4
1CR/relapsed/dead			89/8/6
Sex	M : F		62 : 41
Age at diagnosis (y)			7.43 (0.2–19.2)

ALL: acute lymphoblastic leukemia; NHL: non-Hodgkin’s lymphoma; BCP: B-cell precursor leukemia; T: T-cell linage; CR: complete remission.